arrow_back Civic Audit
Share share

Prohibiting Fetal Tissue Transactions: New Rules for Medical Research

This bill aims to prohibit the sale and transactions related to human fetal tissue. It means that any form of payment, gifts, debt cancellation, or services associated with the acquisition, processing, storage, or transportation of such tissues will be forbidden. This change may impact certain scientific and medical research that utilizes these tissues.
Key points
The act introduces a complete ban on the sale and other forms of compensation for human fetal tissue.
The definition of "valuable consideration" has been expanded to include payments, gifts, fee waivers, and costs associated with transportation or storage of tissues.
These changes may affect the availability of fetal tissue for research and medical purposes, potentially impacting the development of certain therapies and studies.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_7798
Sponsor: Rep. Franklin, C. Scott [R-FL-15]
Process start date: 2022-05-17
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Prohibiting Abortion Industry’s Lucrative Loopholes Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7798.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-17.

What are the main provisions?

Key points include:

  • The act introduces a complete ban on the sale and other forms of compensation for human fetal tissue.
  • The definition of "valuable consideration" has been expanded to include payments, gifts, fee waivers, and costs associated with transportation or storage of tissues.
  • These changes may affect the availability of fetal tissue for research and medical purposes, potentially impacting the development of certain therapies and studies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Franklin, C. Scott [R-FL-15].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Courts and Law